Related Experiment Video
Updated: Feb 12, 2026

Design of a Biocompatible Drug-Eluting Tracheal Stent in Mice with Laryngotracheal Stenosis
Published on: January 21, 2020
Dual Antiplatelet Therapy After Drug-eluting Stent Implantation
Giulia Magnani1, Marco Valgimigli1
1Bern University Hospital, Inselspital, Bern, Switzerland.
Abstract:
The current guidelines for percutaneous coronary intervention use recommend dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 inhibitor after drug eluting stent (DES) implantation. The optimal duration of DAPT is however area of debate. Recent clinical trials and meta-analyses suggest that the choice of DAPT duration should be tailored individually, based on the balance between ischemic and bleeding risk carried by the patient.
Related Concept Videos
Drug Therapy
Antianxiety Medications
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
High-Performance Liquid Chromatography: Elution Process
Hypertension IV: Drug Therapy and Lifestyle Modifications
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

